Mobile

EFFICACY OF EGb 761® 120 mg bid VERSUS PLACEBO IN PATIENTS SUFFERING FROM FRIEDREICH ATAXIA A 3 months, phase II, randomised, double blind, placebo-controlled, parallel groups, clinical study

Update Il y a 4 ans
Reference: EUCTR2007-005371-34

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To demonstrate an improvement in skeletal muscle energetics and particularly in mitochondrial oxidative phosphorylation.

Inclusion criteria

  • Out patient suffering from friedreich ataxia aged from 12 to 20 years

Links